Paul Christopher Duff

Paul Duff practices at Coastal Health in Orange Park, Florida.

Paul Duff's NPI, 1821092503, was assigned on June 9, 2005. Paul Duff holds Florida license PA2397.

Paul Duff's primary practice is Coastal Health, at 705 Wells Rd, Orange Park, FL 32073 in Clay County. The practice phone is (904) 282-6331.

Paul Duff's primary practice is Coastal Health in Orange Park, Florida. Paul Duff is also affiliated with Baptist Medical Center Beaches. The medical group on file is Coastal Health. Dmand AI also links Paul Duff to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Paul Duff practices, 2 sites in all. Vendor and product names are available with a free account.

Medical is Paul Duff's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Paul Duff is board certified in 1991 - 2024 by the FL State PA License. Paul Duff is licensed in Florida.

Dmand AI lists fibromyalgia and chronic pain and lower back pain among the conditions Paul Duff treats.

CMS data shows 1,075 Medicare services from Paul Duff across 3 procedure codes in 2024, for 236 Medicare patients. Medicare paid $115,306 for them. Every service was in an office.

CMS counts 236 Medicare patients who saw Paul Duff in 2024. The largest group is 65 to 74, with 102 patients. 75% of them have arthritis, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Paul Duff's median patient age at 67, with 57% women.

In 2024, Paul Duff wrote 1,820 Medicare Part D claims for 386 patients. 92% of them were for generic drugs. CMS names the drug for 1,714 of them, across 23 drugs with 11 or more claims each, at $92,957 in total drug cost.

Paul Duff accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 225 general payments to Paul Duff from 27 drug and device companies from 2024 to 2025. Speaker and faculty fees make up the largest share, 38% of the total. Medtronic, Inc. paid the most, $16,542.